Citi lowered the firm’s price target on 10x Genomics (TXG) to $15 from $20 and keeps a Buy rating on the shares. The firm updated models in the ...

Genomics, Inc. (NASDAQ:TXG – Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 11,320,000 ...

Genomics (TXG) provided an update on its patent litigation with Parse Biosciences. Through a consent agreement entered on February 25, in ...

Genomics announced that its ATAC-Seq patents were found valid and infringed in its patent litigation with Parse Biosciences.

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived ...

National Bank Financial reduced their FY2025 earnings per share (EPS) estimates for Torex Gold Resources in a note issued to ...

Detailed price information for Torex Gold Resources Inc (TXG-T) from The Globe and Mail including charting and trades.

General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced a series of new ...

Toronto, Ontario--(Newsfile Corp. - February 19, 2025) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports the Company's financial and operational results for the three months ...

Detailed price information for Torex Gold Resources Inc (TXG-T) from The Globe and Mail including charting and trades.